Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
This settlement is closed!
Please see what other class action settlements you might qualify to claim cash from in our Open Settlements directory!
UPDATE 2:
- Top Class Actions viewers reported receiving payments for as much as $2,563.92 as of mid-May 2021.
- Congratulations to everyone who submitted a claim and got paid!
UPDATE:
- According to the settlement website, checks were mailed to approved claimants on May 10, 2021.
- Let Top Class Actions know when you receive a check in the comments section below or on our Facebook page.
A $60 million settlement has been reached between the makers of the opioid addiction medication Suboxone and the Federal Trade Commission.
According to the FTC, Indivior Inc. and its subsidiary Reckitt Benckiser Group, conspired to prevent a lower-priced generic version of Suboxone from interfering with its significant pharmaceutical sales.
The settlement benefits all U.S. consumers who were prescribed Suboxone Film between March 1, 2013 and Feb. 28, 2019. The payout amount will depend on the number of total claims filed and how long the consumer was prescribed Suboxone film.
The FTC anticompetitive lawsuit notes that Indivior falsely marketed its Suboxone Film as being “less susceptible to accidental pediatric exposure than Suboxone Tablets,” right before a generic version of Suboxone tablets entered the market.
This misleading claim reportedly forced many consumers to switch to Suboxone Film which was the more expensive option.
The FTC states that Indivior even went so far as to submit a petition to the Food and Drug Administration in 2012 with statements that “Suboxone Tablets had been discontinued due to safety concerns about the tablet formulation of the drug.”
“In the midst of the nation’s opioid crisis, a critical opioid-addiction treatment was about to become more affordable,” said Gail Levine, a Deputy Director of the FTC’s Bureau of Competition. “But Indivior prevented that. It kept its drug prices high by unlawfully impeding generic manufacturers from competing effectively.”
The Suboxone lawsuit claims that Indivior engaged in improper business practices that didn’t allow competition thus violating Section 5 of the FTC Act.
Under the terms of the FTC settlement, consumers must file a claim no later than Dec. 1, 2020 to get a refund check.
Who’s Eligible
U.S. consumers who were prescribed Suboxone Film between March 1, 2013 and Feb. 28, 2019 are eligible to file a claim for this FTC settlement.
Potential Award
Varies.
The payout amount depends on how long the consumer took Suboxone and how many claims are submitted overall.
Proof of Purchase
Not required at this time. However, consumers are encouraged to save any supporting documents in case the settlement administrator has questions later on.
Claim Form
NOTE: If you do not qualify for this settlement do NOT file a claim.
Remember: you are submitting your claim under penalty of perjury. You are also harming other eligible Class Members by submitting a fraudulent claim. If you’re unsure if you qualify, please read the FAQ section of the Settlement Administrator’s website to ensure you meet all standards (Top Class Actions is not a Settlement Administrator). If you don’t qualify for this settlement, check out our database of other open class action settlements you may be eligible for.
Claim Form Deadline
12/1/2020
Case Name
FTC v. Indivior, Case No. 1:20-cv-00036-JPJ-PMS, and FTC v. Reckitt Benckiser Group PLC, Case No. 1:19-cv-00028, both in the U.S. District Court for the Western District of Virginia, Abingdon
Final Hearing
N/A
Settlement Website
Claims Administrator
Suboxone Claims Center
c/o JND Legal Administration
P.O. Box 91356
Seattle, WA 98111
Info@SuboxoneClaimsCenter.com
1‑877‑545‑0238
Class Counsel
Markus H. Meier
Bradley Albert
Daniel Butrymowicz
Matthew Weprin
FEDERAL TRADE COMMISSION
Defense Counsel
Counsel for Reckitt Benckiser Group:
Howard M. Shapiro
WILMER CUTLER PICKERING HALE
Read About More Class Action Lawsuits & Class Action Settlements:
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
400 thoughts onFTC Opioid Addiction Treatment Suboxone Settlement
Still waiting for my claim as well..
What is the process at this point..
Still waiting for my claim as well..
What is the process at this point.. please send info..thanks.
I filed a claim for this lawsuit in did not hear anything back and did not receive a check in the mail can you help me please.
I took suboxone years ago and its left me with severe teeth problems at 22 i shouldnt be needing 5-6 teeth pulled and have another 4 that are cracked
This is the first i am seeing this is there anything i can do about it or is it too late
Been taking Suboxone for almost 20 years and need to speak with someone regarding teeth compensation
I PUT MY CLAIM IN HAVEN’T HEARD NOTHING OR I’VE BEEN ON SUBOXONE FOR 7YRS PLEASE HELP IN THIS MATTER THANKS
I been on soboxone for 12 years an have all kinds problems
I been on soboxone for 13 or 14 years an there all kinds problems i had due to it.
I thought this would help find out why I didn’t receive a return telephone call from the attorneys about this lawsuit. The information I was sent in the mail was clear on the instructions but now I’m left feeling frustrated because between this and the FTC, there’s been no information or resolution.